<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT201203086918N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2012-08-04</date_registration>
      <primary_sponsor>Deputy of Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>olphactory stimulations and pain control in newborn</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of Breast Milk and Vanilla Odor Venipuncture Response to Pain in Preterm Infants 28-34 Weeks:  Control Randomised Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2012-06-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>150</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/7351</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive.</study_design>
      <phase>N/A</phase>
      <hc_freetext>pain.</hc_freetext>
      <i_freetext>Intervention 1: Newborns of the mother milk group 9-16 hours before the study will be familiarized with their mother’s milk odor by an sterile swap perfumed with mother᾿s milk which its distance from the infant’s nose is 10 cm. Day of the study this group of infants during the 5 minutes before blood sampling, during sampling and 5 minutes after blood sampling by an sterile swap perfumed with mother᾿s milk will be exposed to the Intended smell from 1 cm distance without contact with the infant’s nose and will be evaluated Neonatal pain response using PIPP tool based on the recorded movies.&#13;
&#13;
. Intervention 2: Newborns of the vanilla group 9-16 hours before the study will be familiarized with vanilla Dissolved in glycerol odor by an sterile swap perfumed with vanilla Dissolved in glycerol which its distance from the infant’s nose is 10 cm. Day of the study this group of infants during the 5 minutes before blood sampling, during sampling and 5 minutes after blood sampling by an sterile swap perfumed with vanilla Dissolved in glycerol will be exposed to the Intended smell from 1 cm distance without contact with the infant’s nose and will be evaluated Neonatal pain response using PIPP tool based on the recorded movies.&#13;
&#13;
. Intervention 3: Newborns of the control group will not be familiarized with any odor before the study . Day of the study this group of infants during the 5 minutes before blood sampling, during sampling and 5 minutes after blood sampling  filmed Whereas will be an sterile swap perfumed with sterilel water on 1 cm distance without contact with the infant’s nose and will be evaluated Neonatal pain response using PIPP tool based on the recorded movies. .</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan></results_IPD_plan>
      <results_IPD_description></results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname></firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address></address>
        <city></city>
        <country1></country1>
        <zip></zip>
        <telephone></telephone>
        <email></email>
        <affiliation></affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Seyedrasooli Alehe</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>South Shariety St ; Faculty of Nursing &amp; Midwifery ; Tabriz ; Iran</address>
        <city>tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip></zip>
        <telephone>+98 41 1479 0365</telephone>
        <email>seyyedrasooly@tbzmed.ac.ir</email>
        <affiliation>Faculty of Nursing &amp; Midwifery of Tabriz</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Inclusion criteria:Having 28 to 34 weeks gestational age; Minimum age is 3 days, mother᾿s milk fed; having experienced the pain of previous sampling; drink milk or sweet liquids 30 minutes before the intervention; have not asphyxia, they have stability With specialist neonatal physiologic view; haven’t any congenital malformation Especially in the nose area; haven’t IVH or PVL; haven’t need to surgery; without mecanical ventilation or CPAP; Baby’s have willingness to participate in the study و Exclusion criteria:Baby will be deleted from the study if the diagnosis neuromuscular complications and congenital abnormalities or create any item that would violate the entry criteria; Baby will be deleted from the study if it is not successful obtaining a blood sample with a disposable needle into the skin and need to again try from sampling; Baby will be deleted from the study if recorded films during the intervention are obscure.</inclusion_criteria>
      <agemin>no limit</agemin>
      <agemax>1 year</agemax>
      <gender>Both</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>P07.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other preterm infants.   28 completed weeks or more but less than 37 completed weeks (196 completed days but less than 259 completed days) of gestation.  Prematurity NOS</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Newborns of the mother milk group 9-16 hours before the study will be familiarized with their mother’s milk odor by an sterile swap perfumed with mother᾿s milk which its distance from the infant’s nose is 10 cm. Day of the study this group of infants during the 5 minutes before blood sampling, during sampling and 5 minutes after blood sampling by an sterile swap perfumed with mother᾿s milk will be exposed to the Intended smell from 1 cm distance without contact with the infant’s nose and will be evaluated Neonatal pain response using PIPP tool based on the recorded movies.&#13;
&#13;
.</i_keyword>
      <i_keyword>Newborns of the vanilla group 9-16 hours before the study will be familiarized with vanilla Dissolved in glycerol odor by an sterile swap perfumed with vanilla Dissolved in glycerol which its distance from the infant’s nose is 10 cm. Day of the study this group of infants during the 5 minutes before blood sampling, during sampling and 5 minutes after blood sampling by an sterile swap perfumed with vanilla Dissolved in glycerol will be exposed to the Intended smell from 1 cm distance without contact with the infant’s nose and will be evaluated Neonatal pain response using PIPP tool based on the recorded movies.&#13;
&#13;
.</i_keyword>
      <i_keyword>Newborns of the control group will not be familiarized with any odor before the study . Day of the study this group of infants during the 5 minutes before blood sampling, during sampling and 5 minutes after blood sampling  filmed Whereas will be an sterile swap perfumed with sterilel water on 1 cm distance without contact with the infant’s nose and will be evaluated Neonatal pain response using PIPP tool based on the recorded movies. .</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: 5 minute before blood sampling and during blood sampling and 5 minute after sampling. Method of measurement: with PIPP standard tool.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Deputy of Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2012-06-30</approval_date>
        <contact_name>Tabriz University of Medical Sciences</contact_name>
        <contact_address>tabriz-the end of golgasht street tabriz  Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
